Hysteroscopy Before IVF: When It Helps and When It Is Usually Unnecessary
Key Takeaways
Routine hysteroscopy before a first IVF cycle is not recommended when good-quality ultrasound is normal and there are no uterine symptoms. It may be considered when imaging suggests a cavity abnormality, bleeding is unexplained, adhesions are suspected, or the clinical history warrants a fresh cavity assessment after unsuccessful transfers.
Key evidence: ESHRE Good Practice Recommendations on Recurrent Implantation Failure Cochrane Systematic Review: Hysteroscopy Before Assisted Reproduction inSIGHT Randomized Trial: Routine Hysteroscopy Prior to First IVF
On this page
- Hysteroscopy Before IVF: When It Matters
- Video: Dr. Senai Aksoy’s Clinical Perspective
- Why Routine Screening Is No Longer Recommended
- When Hysteroscopy Is Clinically Indicated
- Repeated Implantation Failure (RIF)
- Diagnostic Hysteroscopy vs Transvaginal Ultrasound
- Decision Framework: Selecting the Right Patients
- FAQ
- Sources
Hysteroscopy Before IVF: When It Matters
Hysteroscopy uses a fine camera to look directly inside the cervix and uterine cavity. If a treatable abnormality is found, some procedures can be performed at the same sitting.
That does not mean everyone needs the test before IVF. The useful question is whether hysteroscopy is likely to change care for this patient, at this point in treatment.
Dr. Aksoy’s Approach
Dr. Aksoy does not recommend routine screening hysteroscopy before a first IVF cycle when good-quality transvaginal ultrasound shows a normal cavity and there are no concerning symptoms. It adds an invasive step without a proven live-birth benefit. Hysteroscopy comes into play when imaging suggests a polyp, a submucosal fibroid or adhesions, when bleeding is unexplained, or when the history after unsuccessful transfers raises a new reason to reassess the cavity. The number of failed transfers is not, by itself, an automatic indication.
Video: Dr. Senai Aksoy’s Clinical Perspective
(Note: The video was recorded in French. Subtitles and audio tracks are available in your YouTube player settings.)
Why Routine Screening Is No Longer Recommended
Some older IVF protocols included hysteroscopy simply so that a small cavity abnormality would not be missed. Better trials have since shown why a routine approach is hard to justify:
- The inSIGHT trial: The Dutch inSIGHT trial (Smit et al., 2016; corrected 2019) found no significant live-birth difference between routine hysteroscopy and immediate IVF in 750 women with a normal ultrasound before a first cycle (53% vs 51%).
- The Cochrane systematic review: A Cochrane review (Kamath et al., 2019) found low-quality evidence that screening hysteroscopy before IVF might raise live birth. The two trials at low risk of bias showed no benefit. The authors concluded that no high-quality evidence supports routine screening in women with a normal ultrasound or hysterosalpingogram.
- ESHRE guidance: ESHRE’s 2023 add-ons recommendations state that screening hysteroscopy is not recommended for routine clinical use and can be considered in recurrent implantation failure (ESHRE add-ons, 2023). Its recurrent implantation failure recommendations likewise say hysteroscopy may be considered, especially when ultrasound suggests a uterine abnormality (ESHRE, 2023).
When Hysteroscopy Is Clinically Indicated
Hysteroscopy is more likely to add useful information when there is a specific clinical reason to inspect the cavity:
- A suspected endometrial polyp: Ultrasound or saline-infusion sonography may show a focal lesion that needs clarification or treatment planning.
- A submucosal or cavity-distorting fibroid: Hysteroscopy can define an intracavitary component and, in selected cases, allow treatment.
- Intrauterine Adhesions (Asherman Syndrome): Previous curettage, operative termination, or severe endometritis can cause fibrous bands that restrict endometrial expansion.
- A suspected uterine septum: Diagnosis requires assessment of both the inner and outer uterine contour. If a septum is confirmed, the effect of incision on live birth in infertility remains uncertain and should be discussed through shared decision-making (ASRM, 2024; Cochrane, 2025).
- A reason to investigate chronic endometritis: Hysteroscopic appearances are only moderately accurate on their own (pooled sensitivity and specificity of about 80% in a 2026 meta-analysis, Pérez Milán et al., 2026). When clinically appropriate, an endometrial biopsy with histology and CD138 assessment may be considered.
Repeated Implantation Failure (RIF)
Repeated unsuccessful transfers deserve a review of the whole clinical picture. They do not automatically make hysteroscopy beneficial, and ESHRE advises an individualised assessment rather than a fixed definition based only on the number of transfers.
The strongest randomised evidence points the same way. In the TROPHY trial, women with a normal ultrasound and two to four previous unsuccessful IVF cycles had the same live-birth rate with or without outpatient hysteroscopy: 29% in each group. The 2026 ASRM committee opinion describes repeat evaluation of the cavity after repeated failed transfers as reasonable to offer, and notes that hysteroscopy can treat a lesion if one is found (ASRM, 2026).
Some meta-analyses have reported a possible benefit, but they combine studies of different quality (Cao et al., 2018). A reasonable approach is to look for a new indication, such as suspicious imaging, unexplained bleeding or possible adhesions, rather than to scope routinely after a fixed number of transfers.
Diagnostic Hysteroscopy vs Transvaginal Ultrasound
| Feature | High-Resolution 2D/3D Ultrasound | Office / Diagnostic Hysteroscopy |
|---|---|---|
| Invasiveness | Non-invasive | Minimally invasive (endoscopic) |
| Primary Utility | First-line assessment of the myometrium, ovaries and cavity | Direct view of the uterine lining, with treatment when appropriate |
| Cavity pathology | Useful first-line assessment; saline infusion can improve cavity detail | Direct inspection; may confirm and sometimes treat a suspected lesion |
| When to choose | Usually part of the initial fertility assessment | Consider if imaging is suspicious, bleeding is unexplained, adhesions are possible, or reassessment after failed transfers has a clear rationale |
Decision Framework: Selecting the Right Patients
| Clinical Situation | Recommended Strategy | Rationale |
|---|---|---|
| First IVF cycle + normal ultrasound | Proceed directly to IVF without hysteroscopy | No demonstrated increase in live birth; avoids unnecessary cost and delay |
| First IVF cycle + suspicious cavity | Confirm the finding; use hysteroscopy if it will clarify or treat it | Management depends on the lesion; a suspected septum requires separate imaging and shared decision-making |
| Unsuccessful transfers + normal imaging | Review the full case; do not use a fixed transfer count alone | TROPHY found no live-birth benefit from routine hysteroscopy after two to four failed IVF cycles |
| History of uterine curettage / light menses | Diagnostic hysteroscopy | Excludes intrauterine adhesions and evaluates cavity volume |
Frequently Asked Questions for Dr. Aksoy
Is hysteroscopy mandatory before IVF or frozen embryo transfer?
No. Hysteroscopy is not required before every IVF cycle or every frozen embryo transfer.
Some patients think that looking inside the uterus with a camera before transfer will necessarily improve the chance of implantation. If the cavity looks normal, there are no symptoms, and there is no other suspicious finding, we do not have strong evidence that routine hysteroscopy increases the live-birth rate.
I first assess the uterine cavity with ultrasound. When I think it is needed, I may also use three-dimensional ultrasound or a saline-infusion ultrasound.
When do I recommend hysteroscopy?
For example, if I suspect a polyp, adhesions, a fibroid that reaches into the cavity, or another abnormality, hysteroscopy can be very useful. We can see the problem directly and, in some cases, treat it in the same procedure.
After repeated unsuccessful embryo transfers I also find it reasonable to reassess the cavity. Even then I do not do hysteroscopy automatically in every patient. I first review the previous scans, the embryos and how the transfers were done.
The same applies to frozen embryo transfer. The fact that the embryo is frozen does not, on its own, mean hysteroscopy is needed.
What matters to me is not adding another procedure before every transfer. It is whether there is a uterine problem that could affect implantation and that we can actually treat.
FAQ
Can diagnostic hysteroscopy be performed in the office without general anaesthesia?
Often, yes. A thin hysteroscope can frequently be used in an outpatient setting without general anaesthesia. Pain experience varies, so analgesia and anaesthesia options should be discussed before the procedure.
Does removing an endometrial polyp during hysteroscopy improve IVF success?
It may be appropriate when a polyp is thought to distort the cavity or contribute to symptoms, but IVF-specific evidence is limited and not every small polyp needs removal. The decision should take account of size, location, symptoms, treatment timing and the uncertainty around live-birth benefit. The one randomised trial of removing small polyps and fibroids in infertility (HELP Fertility) closed early with 35 of 1,120 planned participants, so it cannot settle the question (Metwally et al., 2026).
What is the best timing for hysteroscopy in my menstrual cycle?
For patients who menstruate, diagnostic hysteroscopy is often scheduled after bleeding has ended and before ovulation, when the lining is thinner and pregnancy can be excluded. Timing may differ with irregular cycles, hormonal preparation or an urgent clinical indication.
Related Reading
- Role of Hysteroscopy in Improving Fertility: Evidence and Clinical Guidelines
- Candidates for Hysteroscopy: When Is Uterine Endoscopy Indicated?
- Chronic Endometritis and IVF: Silent Inflammation, Biopsy & Treatment
- Hysteroscopic Surgery for Adenomyosis: Indications and Limits
Sources
- European Society of Human Reproduction and Embryology (ESHRE). Good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023.
- ESHRE Add-ons Working Group. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062-2104.
- Practice Committee of the American Society for Reproductive Medicine. Recurrent implantation failure: a committee opinion. Fertil Steril. 2026;126:277-293.
- Kamath MS, Bosteels J, D’Hooghe TM, et al. Screening hysteroscopy in subfertile women and women undergoing assisted reproduction. Cochrane Database Syst Rev. 2019;4:CD012856. PMID 30991443.
- Smit JG, Kasius JC, Eijkemans MJC, et al. Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial. Lancet. 2016;387(10038):2622-2629. Corrected live-birth figures: Smit JG, et al. Ongoing pregnancy as the primary outcome for the inSIGHT study. Lancet. 2019.
- El-Toukhy T, et al. Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial. Lancet. 2016;387(10038):2614-2621.
- Cao H, et al. Hysteroscopy after repeated implantation failure of assisted reproductive technology: a meta-analysis. J Obstet Gynaecol Res. 2018;44(3):365-373.
- American Society for Reproductive Medicine. Evidence-based diagnosis and treatment for uterine septum: a guideline. Fertil Steril. 2024;122:251-265.
- Joosse MI, Kostova EB, Rikken JF, et al. Septum resection for women of reproductive age with a septate uterus. Cochrane Database Syst Rev. 2025;11:CD008576.
- Metwally M, McKendrick K, Ridsdale K, et al. Removal of small fibroids and polyps in patients with infertility and recurrent miscarriage: the HELP Fertility? RCT. Health Technol Assess. 2026;30(62):85-120.
- Pérez Milán F, Caballero Campo M, Domínguez Arroyo JA, et al. Diagnostic accuracy of hysteroscopy for chronic endometritis in reproductive-age and infertile women: a systematic review and latent class meta-analysis. J Minim Invasive Gynecol. 2026;33:898-912.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.